Answers are grounded in this paper and cite their sources.
Cervical cancer progresses from persistent high-risk human papillomavirus (HPV) infection through low-grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions to invasive squamous cell carcinoma (SCC), yet current triage tools—cytology, HPV genotyping, and colposcopy—cannot reliably distinguish lesions that need surgical intervention from those that regress. Cervicovaginal fluid (CVF) directly contacts the cervical transformation zone and is an attractive, non-invasively collected substrate for biomarker discovery. Comprehensive label-free proteomic profiling (HPLC-DDA-PASEF-MS/MS) of CVF was performed in 93 women spanning the full histological spectrum of HPV-associated cervical disease: HPV-negative controls (NILM, n = 18), HPV-positive inflammatory disease of the cervix (IDC, n = 17), LSIL (n = 20), HSIL (n = 20), and SCC (n = 18). Of 1,476 proteins detected (1,219 quantified), 106 CVF proteins met strict criteria (≥3 unique peptides) and differed significantly in at least one pairwise comparison (IDC, LSIL, HSIL, SCC vs. NILM). The CVF proteome underwent progressive remodeling with disease severity, with the number of differentially expressed proteins (DEPs, |FC| > 2, p < 0.05) rising from 13 in IDC and 6 in LSIL to 43 in HSIL and 100 in SCC relative to NILM. The most robust discrimination between disease requiring intervention (HSIL and SCC) and conditions suited to surveillance (NILM, IDC, and LSIL) was driven not by epithelial proteins but by a coordinated plasma protein signature—CPN2, ORM2, AGT, KNG1, F2, ITIH1, GC, APOA1, SERPINA1, and C4A—all among the top 5% most abundant plasma proteins, reflecting epithelial barrier disruption, acute-phase response, and hemostatic activation. Pathway analysis converged on platelet activation and degranulation, complement and coagulation cascades, neutrophil degranulation, IGF transport and uptake, and keratinization across comparisons. TRIM29 (R = −0.63) and AHNAK2 (R = −0.61) showed the strongest negative correlations with lesion grade, whereas IGHM (R = 0.55), AGT (R = 0.53), and ITIH1 (R = 0.53) increased with grade. A subset of proteins, including ACTN4, PSMA3, ACP1, EIF5AL1, IGFBP2, KNG1, EIF5A, and ORM2, overlapped between inflammatory and neoplastic processes, indicating that HPV-driven inflammation alone can partially mimic a neoplastic CVF signature. These data position CVF proteomics as a promising non-invasive approach for triaging HPV-associated cervical pathology and suggest that a multi-protein panel centered on the APOA1/ORM2/KNG1/SERPINA1 axis, combined with grade-associated epithelial proteins such as TRIM29 and AHNAK2, warrants validation in independent, well-characterized cohorts.
No takes yet. Share an insight, caveat, or question.
Starodubtseva et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: